Human carbohydrate antigen 19-9 (CA 19-9) from metastatic liver carcinoma, Native, 90%

Cat. No.: XCA-009Q

Human carbohydrate antigen 19-9 (CA 19-9) from metastatic liver carcinoma, Native, 90%

Synonym: Tumor marker 19-9; CA 19-9; Cancer antigen 19-9; Sialylated lewis (a) antigen; SIAT7F; SIAT7-F; ST6GALNACVI; ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6

Product Size
25 KU
Price
Datasheet
MSDS
Properties
Description
Human carbohydrate antigen 19-9 (CA 19-9) was extracted from human liver carcinoma. This product can be used as immunogen, control, and also can be used in immunoassays, such as ELISA and WB.
Host
Human
Activity
1,000 KU/mL
Purity
90%, determined by SDS-PAGE, purified by ion exchange chromatography.
Source
Human metastatic liver carcinoma
Cross-Reactivity
Low cross contamination
Form
Liquid
Buffer
0.1 M PBS (pH 7.4) with sucrose
Preservative
0.05% Sodium azide
Applications
Immunogen, Control, ELISA, WB.
Storage
Store at -80°C.
Gene Information
Common Name
ST6GALNAC6
Full Name
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
Gene ID
Uniprot ID
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.